148 related articles for article (PubMed ID: 21064135)
1. Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases.
Yoo KH; Lee SH; Sung KW; Koo HH; Chung NG; Cho B; Kim HK; Kang HJ; Shin HY; Ahn HS; Baek HJ; Han DK; Kook H; Hwang TJ; Kim SY; Lee YH; Hah JO; Im HJ; Seo JJ; Park SK; Jung HJ; Park JE; Lim YJ; Park SS; Lim YT; Yoo ES; Ryu KH; Park HJ; Park BK
Am J Hematol; 2011 Jan; 86(1):12-7. PubMed ID: 21064135
[TBL] [Abstract][Full Text] [Related]
2. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
[TBL] [Abstract][Full Text] [Related]
3. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
[TBL] [Abstract][Full Text] [Related]
4. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
[TBL] [Abstract][Full Text] [Related]
5. Higher CD34(+) and CD3(+) cell doses in the graft promote long-term survival, and have no impact on the incidence of severe acute or chronic graft-versus-host disease after in vivo T cell-depleted unrelated donor hematopoietic stem cell transplantation in children.
Kałwak K; Porwolik J; Mielcarek M; Gorczyńska E; Owoc-Lempach J; Ussowicz M; Dyla A; Musiał J; Paździor D; Turkiewicz D; Chybicka A
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1388-401. PubMed ID: 20382248
[TBL] [Abstract][Full Text] [Related]
6. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
Laughlin MJ; Eapen M; Rubinstein P; Wagner JE; Zhang MJ; Champlin RE; Stevens C; Barker JN; Gale RP; Lazarus HM; Marks DI; van Rood JJ; Scaradavou A; Horowitz MM
N Engl J Med; 2004 Nov; 351(22):2265-75. PubMed ID: 15564543
[TBL] [Abstract][Full Text] [Related]
9. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
Laughlin MJ; Barker J; Bambach B; Koc ON; Rizzieri DA; Wagner JE; Gerson SL; Lazarus HM; Cairo M; Stevens CE; Rubinstein P; Kurtzberg J
N Engl J Med; 2001 Jun; 344(24):1815-22. PubMed ID: 11407342
[TBL] [Abstract][Full Text] [Related]
11. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
[TBL] [Abstract][Full Text] [Related]
12. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
13. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation.
Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M
Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939
[TBL] [Abstract][Full Text] [Related]
14. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of unrelated cord blood transplantation in pediatric recipients.
Styczynski J; Cheung YK; Garvin J; Savage DG; Billote GB; Harrison L; Skerrett D; Wolownik K; Wischhover C; Hawks R; Bradley MB; Del Toro G; George D; Yamashiro D; van de Ven C; Cairo MS
Bone Marrow Transplant; 2004 Jul; 34(2):129-36. PubMed ID: 15107815
[TBL] [Abstract][Full Text] [Related]
16. Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringdén O; Uhlin M; Mattsson J
Transplantation; 2012 Nov; 94(10):1066-74. PubMed ID: 23076550
[TBL] [Abstract][Full Text] [Related]
17. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
Sanz GF; Saavedra S; Jiménez C; Senent L; Cervera J; Planelles D; Bolufer P; Larrea L; Martín G; Martínez J; Jarque I; Moscardó F; Plumé G; Andreu R; de la Rubia J; Barragán E; Solves P; Soler MA; Sanz MA
Bone Marrow Transplant; 2001 Apr; 27(7):693-701. PubMed ID: 11360108
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units.
Yin Y; Ren HY; Cen XA; Qiu ZX; Ou JP; Wang WS; Wang MJ; Xu WL; Wang LH; Li Y; Dong YJ
Chin Med J (Engl); 2011 Aug; 124(16):2411-6. PubMed ID: 21933579
[TBL] [Abstract][Full Text] [Related]
19. Early identification and management of graft failure after unrelated cord blood transplantation.
Chan KW; Grimley MS; Taylor C; Wall DA
Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
[TBL] [Abstract][Full Text] [Related]
20. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.
Gluckman E; Rocha V; Boyer-Chammard A; Locatelli F; Arcese W; Pasquini R; Ortega J; Souillet G; Ferreira E; Laporte JP; Fernandez M; Chastang C
N Engl J Med; 1997 Aug; 337(6):373-81. PubMed ID: 9241126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
